Should an abnormal serum potassium concentration be considered a correctable cause of cardiac arrest?

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 1224-1225

  Michaud, Gregory F ^b   Strickberger, S Adam ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; POTASSIUM; SPIRONOLACTONE;

CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; ELECTROLYTE DISTURBANCE; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; STEADY STATE; TREATMENT INDICATION;

EID: 0034806586     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01508-X     Document Type: Editorial

References (6)

1. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary
2. Hypokalemia as a cause of cardiac arrest: Results of electrophysiologic testing and long-term follow up
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
4. Design and results of the Antiarrhythmics Vs. Implantable Defibrillators registry
5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
6. Relationship between serum potassium concentration during a primary ventricular arrhythmia and the risk of a subsequent arrhythmic event in patients with an implantable defibrillator